P0810 : Sofosbuvir and daclatasvir combined treatment for chronic hepatitis C: First-year efficacy and safety data in a real-life setting

2015 ◽  
Vol 62 ◽  
pp. S639
Author(s):  
A.-J. Rémy ◽  
A. Pariente ◽  
J.-P. Arpurt ◽  
I. Rosa-Hézode ◽  
C. Renou ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Combined Treatment ◽  
Safety Data ◽  
Real Life ◽  
First Year ◽  
Efficacy And Safety ◽  
Real Life Setting

Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003–2007)

2011 ◽  
Vol 17 (1) ◽  
pp. 101-110 ◽  
Author(s):  
Marc Bourlière ◽  
Denis Ouzan ◽  
Michel Rosenheim ◽  
Michel Doffoël ◽  
Patrick Marcellin ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Real Life ◽  
Pegylated Interferon ◽  
Real Life Setting ◽  
Interferon Α2a ◽  
French Cohort

Real‐life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong

2017 ◽  
Vol 32 (6) ◽  
pp. 1230-1233 ◽  
Author(s):  
Henry Lik‐Yuen Chan ◽  
Owen Tak‐Yin Tsang ◽  
Yee‐Tak Hui ◽  
James Fung ◽  
Grace Chung‐Yan Lui ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hong Kong ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Real Life ◽  
Efficacy And Safety ◽  
Chronic Hepatitis C Patients
Sign in / Sign up

Export Citation Format

Share Document